Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001096906-25-000861
Filing Date
2025-05-20
Accepted
2025-05-19 21:35:12
Documents
63
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 AIBIOTICS THERAPIES, INC. - FORM 10-Q SEC FILING tpia-20250331.htm   iXBRL 10-Q 493110
2 CERTIFICATION OF PRINCIPAL EXECUTIVE AND PRINCIPAL FINANCIAL OFFICER PURSUANT TO tpia_ex31z1.htm EX-31.1 8509
3 CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER PURSUANT TO tpia_ex32z1.htm EX-32.1 4512
  Complete submission text file 0001096906-25-000861.txt   2758923

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT tpia-20250331_cal.xml EX-101.CAL 18708
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT tpia-20250331_def.xml EX-101.DEF 84709
6 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT tpia-20250331_lab.xml EX-101.LAB 152159
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT tpia-20250331_pre.xml EX-101.PRE 145838
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT tpia-20250331.xsd EX-101.SCH 36065
66 EXTRACTED XBRL INSTANCE DOCUMENT tpia-20250331_htm.xml XML 380646
Mailing Address 480 22ND STREET HEYBURN ID 83336
Business Address 480 22ND STREET HEYBURN ID 83336 208-677-2020
AIBOTICS, INC. (Filer) CIK: 0001763329 (see all company filings)

EIN.: 870645794 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-56022 | Film No.: 25966007
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)